ZP GENERAL PARTNER 1 ApS: Financial statements 2018
CVR: 36402660
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ZP GENERAL PARTNER 1 ApS (CVR 36402660) has filed annual accounts for 2018. In 2018, the company reported a net result of USD -1,000 compared with USD -2,000 the year before. Equity in the 2018 report amounted to USD 2,000. The solvency ratio was 66.7%.
- Profit/Loss
- USD -1,000
- Equity
- USD 2,000
- Total Assets
- USD 3,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -1 t. USD | 2 t. USD | - |
| 2017 | - | - | -2 t. USD | 3 t. USD | - |
| 2016 | - | - | -3 USD | 5 USD | - |
| 2015 | 0 USD | 0 USD | -4 USD | 8 USD | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ZP GENERAL PARTNER 1 ApS has published its annual report for 2017. The net result was DKK -2,000.
About ZP GENERAL PARTNER 1 ApS
ZP GENERAL PARTNER 1 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported revenue of DKK 2,000 and a net result of DKK -26,000 compared with DKK -14,000 the year before. Equity in the 2025 report amounted to DKK 81,000.